Driscoll Frederick W
SEC-identified person · CIK 1129890 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| MEI Pharma, Inc. MSHL | Director | filed 2018 - 2025 |
| Cellectar Biosciences, Inc. clrB | Director | filed 2017 - 2025 |
| Cue Biopharma, Inc. CUE | Director | filed 2018 - 2025 |
| Invivyd, Inc. IVVD | Interim CFO | filed 2022 - 2022 |
| Renovacor, Inc. RCOR | Chief Financial Officer | filed 2022 - 2022 |
| Flexion Therapeutics Inc FLXN | Chief Financial Officer | filed 2014 - 2021 |
| Nantkwest, Inc. NK | Director | filed 2017 - 2020 |
| Conformis Inc CFMS | INTERIM CFO & INTERIM TREAS | filed 2019 - 2019 |
| Abpro Corp ABP | Director | filed 2018 - 2018 |
| Oncotelic Therapeutics, Inc. OXGN | Director | filed 2014 - 2016 |
| Novavax INC nvax | VP, CFO & Treasurer | filed 2009 - 2013 |
| Genelabs Technologies INC /CA swtx | CFO | filed 2007 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.